本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Embecta Corp.

11.87
-0.7850-6.21%
成交量:12.97萬
成交額:156.75萬
市值:6.90億
市盈率:11.99
高:12.28
開:12.26
低:11.87
收:12.65
資料載入中...

公司資料

公司名字:
Embecta Corp.
交易所:
NASDAQ
成立時間:
1924
員工人數:
2100
公司地址:
300 Kimball Drive,Suite 300,Parsippany,New Jersey,United States
郵編:
07054
電話:
傳真:
- -
簡介:
Embecta Corp.於2021年7月8日在特拉華州成立。該公司是一家全球領先的醫療器械公司,專註於提供解決方案以改善糖尿病患者的健康和福祉。在該公司95年的業務歷史中,該公司相信產品已成為世界上糖尿病管理領域最廣泛認可和最受尊敬的品牌之一。該公司估計,該公司的產品被100多個國家的近3000萬人用於胰島素和糖尿病的日常管理。該公司擁有廣泛的上市產品組合,包括各種筆針、注射器和安全設備,並輔以旨在幫助人們管理糖尿病的專有数字應用程序。

董事

名稱
職位
David F. Melcher
Non-Executive Chairman
Devdatt Kurdikar
Director,President and Chief Executive Officer
Carrie L. Anderson
Director
Christopher R. Reidy
Director
Claire Pomeroy
Director
David J. Albritton
Director
Karen N. Prange
Director
Milton M. Morris
Director
Robert J. Hombach
Director

股東

名稱
職位
Devdatt Kurdikar
Director,President and Chief Executive Officer
Ajay Kumar
Senior Vice President and Chief Human Resources Officer
Colleen Riley
Senior Vice President and Chief Technology Officer
Ginny Blocki
Senior Vice President, Product Management and Global Marketing
Jacob Elguicze
Senior Vice President and Chief Financial Officer
Jeff Mann
Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
Shaun Curtis
Senior Vice President, Global Manufacturing and Supply Chain
Slobodan Radumilo
Senior Vice President and President, International
Tom Blount
Senior Vice President and President, North America
Brian Capone
Vice President, Chief Accounting Officer and Corporate Controller